Pneumococcal 21-valent conjugate vaccine (Sanofi)

21价肺炎球菌多糖结合疫苗（赛诺菲）

Report date: 2026/03/06 20:02:51

Base Information

Drug NamePneumococcal 21-valent conjugate vaccine (Sanofi)
Drug Alias NameN/A
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSanofi Pasteur Inc
China Registration ClassN/A

Develop Information

Active CompaniesSanofi Pasteur IncSk Bioscience Co LtdShenzhen Sanofi Pasteur Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsPneumococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia